DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 55.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2011Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literatureHosson, L.D. de; Warrenburg, B.P.C. van de; Preijers, F.W.M.B.; Blijlevens, N.M.A.; Reijden, B.A. van der; Kremer, H.P.H.; Lefeber, D.J.; Allebes, W.A.; Al-Ali, H.; Niederwieser, D.W.; Schaap, N.P.M.; Schattenberg, A.V.M.B.
2011Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasiaLodewyck, T.; Oudshoorn, M.; Holt, B. van der; Petersen, E.; Spierings, E.; Borne, P. von dem; Schattenberg, A.V.M.B.; Allebes, W.A.; Groenendijk-Sijnke, M.; Duinhouwer, L.; Willemze, R.; Lowenberg, B.; Verdonck, L.F.; Meijer, E.; Cornelissen, J.J.
2011Shortest exposure time possible with LED curing lightsBusemann, I.; Lipke, C.; Schattenberg, A.V.M.B.; Willershausen, B.; Ernst, C.P.
2010Autologe stamceltransplantatie bij hematologische aandoeningen, 1980-2002Beckers, M.M.; Verdonck, L.F.; Cornelissen, J.J.; Schattenberg, A.V.M.B.; Janssen, J.J.M.; Willemze, R.; Imhoff, G.W. van; Lelie, J.H. van der; Wijermans, P.; Schaafsma, R.; Baars, J.; Marwijk Kooij, M.R. van; Biesma, D.H.; Biezen, A. van; Brand, R.; Schouten, H.C.
2010Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.Deenik, W.; Janssen, J.J.M.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J.; Daenen, S.M.G.J.; Verdonck, L.F.; Ferrant, A.; Schattenberg, A.V.M.B.; Sonneveld, P.; Marwijk Kooy, M. van; Wittebol, S.; Willemze, R.; Wijermans, P.W.; Beverloo, H.B.; Lowenberg, B.; Valk, P.J.; Ossenkoppele, G.J.; Cornelissen, J.J.
2010Allogeneic stem-cell transplantation in patients with Waldenstrom macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.Kyriakou, C.; Canals, C.; Cornelissen, J.J.; Socie, G.; Willemze, R.; Ifrah, N.; Greinix, H.T.; Blaise, D.; Deconinck, E.; Ferrant, A.; Schattenberg, A.V.M.B.; Harousseau, J.L.; Sureda, A.; Schmitz, N.
2010CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A.Eissens, D.N.; Schaap, N.P.M.; Preijers, F.W.M.B.; Dolstra, H.; Cranenbroek, B. van; Schattenberg, A.V.M.B.; Joosten, I.; Meer, A. van der
2010Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.Chalandon, Y.; Passweg, J.R.; Schmid, C.; Olavarria, E.; Dazzi, F.; Simula, M.P.; Ljungman, P.; Schattenberg, A.V.M.B.; Witte, T.J.M. de; Lenhoff, S.; Jacobs, P.W.M.; Volin, L.; Iacobelli, S.; Finke, J.; Niederwieser, D.; Guglielmi, C.
2009Isolated acral dermatitis due to graft-versus-host disease.Velden, W.J.F.M. van der; Lesterhuis, W.J.; Blokx, W.A.M.; Schattenberg, A.V.M.B.
2009Allogene stamceltransplantatie in NederlandSchattenberg, A.V.M.B.; Schouten, H.C.; Verdonck, L.F.; Willemze, R.; Lelie, J. van der; Huijgens, P.C.; Imhoff, G.W. van; Biezen, A. van; Brand, R.; Hagenbeek, A.; Witte, T.J.M. de; Cornelissen, J.J.
2009Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.Avivi, I.; Montoto, S.; Canals, C.; Maertens, J.; Al-Ali, H.K.; Mufti, G.J.; Finke, J.; Schattenberg, A.V.M.B.; Fanin, R.; Cornelissen, J.J.; Vernant, J.P.; Russell, N.; Beguin, Y.; Thomson, K.; Verdonck, L.F.; Kobbe, G.; Tilly, H.; Socie, G.; Sureda, A.
2009Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.Norde, W.J.; Overes, I.M.; Maas, F.M.H.M.; Fredrix, J.M.; Vos, A.; Kester, M.G.; Voort, R. van der; Jedema, I.; Falkenburg, J.H.F.; Schattenberg, A.V.M.B.; Witte, T.J.M. de; Dolstra, H.
2008Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.Kempen-Harteveld, ML van; Brand, R.; Kal, H.B.; Verdonck, L.F.; Hofman, P.; Schattenberg, A.V.M.B.; Maazen, R.W.M. van der; Cornelissen, J.J.L.M.; Eijkenboom, W.M.H.; Lelie, JP van der; Oldenburger, F.; Barge, R.M.; Biezen, A. van; Vossen, J.M.J.J.; Noordijk, E.M.; Struikmans, H.
2008Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.Deenik, W.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J.; Kluin-Nelemans, H.C.; Verdonck, L.F.; Ferrant, A.; Schattenberg, A.V.M.B.; Janssen, J.J.H.M.; Sonneveld, P.; Kooy, M van Marwijk; Wittebol, S.; Willemze, R.; Wijermans, P.W.; Westveer, P.H.; Beverloo, H.B.; Valk, P. van de; Lowenberg, B.; Ossenkoppele, G.J.; Cornelissen, J.J.L.M.
2008Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.Vonk, M.C.; Marjanovic, Z.; Hoogen, F.H.J. van den; Zohar, S.; Schattenberg, A.V.M.B.; Fibbe, W.E.; Larghero, J.; Gluckman, E.; Preijers, F.W.; Dijk, A.P. van; Bax, J.J.; Roblot, P.; Riel, P.L.C.M. van; Laar, J.M. van; Farge, D.
2008KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.Meer, A. van der; Schaap, N.P.M.; Schattenberg, A.V.M.B.; Cranenbroek, B. van; Tijssen, H.J.; Joosten, I.
2007Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.Schrezenmeier, H.; Passweg, J.R.; Marsh, J.C.; Bacigalupo, A.; Bredeson, C.N.; Bullorsky, E.; Camitta, B.M.; Champlin, R.E.; Gale, R.P.; Fuhrer, M.; Klein, J.P.; Locasciulli, A.; Oneto, R.; Schattenberg, A.V.M.B.; Socie, G.; Eapen, M.
2007Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival.Levenga, H.; Levison-Keating, S.; Schattenberg, A.V.M.B.; Dolstra, H.; Schaap, N.P.M.; Raymakers, R.A.P.
2007Experience of severe fatigue in long-term survivors of stem cell transplantation.Gielissen, M.F.M.; Schattenberg, A.V.M.B.; Verhagen, C.A.H.H.V.; Rinkes, M.J.; Bremmers, M.E.J.; Bleijenberg, G.
2007High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia : A prospective randomized phase III studyDeenik, W.; Holt, B. van der; Verhoef, G.E.; Schattenberg, A.V.M.B.; Verdonck, L.F.; Daenen, S.M.G.J.; Zachee, P.; Westveer, P.H.; Smit, W.M.; Wittebol, S.; Schouten, H.C.; Lowenberg, B.; Ossenkoppele, G.J.; Cornelissen, J.J.L.M.
2007Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.Levenga, H.; Woestenenk, R.M.; Schattenberg, A.V.M.B.; Maas, F.M.H.; Jansen, J.H.; Raymakers, R.A.P.; Mulder, P.H.M. de; Wiel-van Kemenade, E. van de; Schaap, N.P.M.; Witte, T.J.M. de; Dolstra, H.
2007Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.Gahrton, G.; Iacobelli, S.; Bandini, G.; Bjorkstrand, B.; Corradini, P.; Crawley, C.; Hegenbart, U.; Morgan, G.; Kroger, N.; Schattenberg, A.V.M.B.; Schonland, S.O.; Verdonck, L.F.; Volin, L.; Witte, T.J.M. de; Niederwieser, D.
2006The experience of severe fatigue in long term survivors of stem-cell transplantation.Gielissen, M.F.M.; Schattenberg, A.V.M.B.; Verhagen, S.; Rinkes, M.J.; Bleijenberg, G.
2006A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.Schattenberg, A.V.M.B.; Baynes, C.; Dijk, M.C.R.F. van; Koster, A.; Cleef, P.H. van; Preijers, F.W.M.B.; Hermus, A.R.M.M.; Raemaekers, J.M.M.
2006The origin of epithelial neoplasms after allogeneic stem cell transplantation.Smith, M.J.; Cleef, P.H. van; Schattenberg, A.V.M.B.; Krieken, J.H.J.M. van
2006Differences between the different conditioning regimens for allogeneic stem cell transplantation.Schattenberg, A.V.M.B.; Levenga, T.H.
2006Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation.Claessens, J.J.M.; Beerendonk, C.C.M.; Schattenberg, A.V.M.B.
2006Invriezen van navelstrengbloed en beenmerg voor eigen gebruik : hedendaagse kwakzalverij?Braat, D.D.M.; Mummery, C.L.; Schattenberg, A.V.M.B.; Borst-Eilers, E.
2006Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients.Hendriks, M.P.; Blijlevens, N.M.A.; Schattenberg, A.V.M.B.; Burger, D.M.; Donnelly, J.P.
2005Cellular adoptive immunotherapy after allogeneic stem cell transplantation.Schattenberg, A.V.M.B.; Dolstra, H.
2005The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.Gahrton, G.; Iacobelli, S.; Apperley, J.; Bandini, G.; Bjorkstrand, B.; Blade, J.; Boiron, J.M.; Cavo, M.; Cornelissen, J.J.L.M.; Corradini, P.; Kroger, N.; Ljungman, P.; Michallet, M.; Russell, N.H.; Samson, D.; Schattenberg, A.V.M.B.; Sirohi, B.; Verdonck, L.F.; Volin, L.; Zander, A.; Niederwieser, D.
2005A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.Blijlevens, N.M.A.; Donnelly, J.P.; Naber, A.H.J.; Schattenberg, A.V.M.B.; Pauw, B.E. de
2005A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.Rijke, B. de; Horssen-Zoetbrood, A. van; Beekman, J.M.; Otterud, B.; Maas, F.M.H.; Woestenenk, R.M.; Kester, M.; Leppert, M.; Schattenberg, A.V.M.B.; Witte, T.J.M. de; Wiel-van Kemenade, E. van de; Dolstra, H.
2005Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.Straaten, H.M. van der; Biezen, A. van; Brand, R.; Schattenberg, A.V.M.B.; Egeler, R.M.; Barge, R.M.; Cornelissen, J.J.L.M.; Schouten, H.C.; Ossenkoppele, G.J.; Verdonck, L.F.
2004Citrulline : a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapyBlijlevens, N.M.A.; Lutgens, L.C.; Schattenberg, A.V.M.B.; Donnelly, J.P.
2004Bone marrow transplantation after processing by gradients and negative immunomagnetic T- and B-cell selection to prevent GvHD without loss of engraftment potentialPreijers, F.W.M.B.; Schattenberg, A.V.M.B.; Ruijs, W.P.M.; Trilsbeek, C.
2004The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.Lokhorst, H.M.; Wu, K.; Verdonck, L.F.; Laterveer, L.; Donk, N.W. van de; Oers, M.H. van; Cornelissen, J.J.L.M.; Schattenberg, A.V.M.B.
2004Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors.Schattenberg, A.V.M.B.; Meer, A. van der; Preijers, F.W.M.B.; Schaap, N.P.M.; Rinkes, M.J.; Maazen, R.W.M. van der; Allebes, W.A.; Joosten, I.; Witte, T.J.M. de
2004Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.Farge, D.; Passweg, J.R.; Laar, J.M. van; Marjanovic, Z.; Besenthal, C.; Finke, J.; Peter, H.H.; Breedveld, F.C.; Fibbe, W.; Black, C.; Denton, C.; Koetter, I.; Locatelli, F.; Martini, A.; Schattenberg, A.V.M.B.; Hoogen, F.H.J. van den; Putte, L.B.A. van de; Lanza, F.; Arnold, R.; Bacon, P.A.; Bingham, S.; Ciceri, F.; Didier, B.; Diez-Martin, J.L.; Emery, P.; Feremans, W.; Hertenstein, B.; Hiepe, F.; Luosujarvi, R.; Leon Lara, A.; Marmont, A.; Martinez, A.; Pascual Cascon, H.; Bocelli-Tyndall, C.; Gluckman, E.; Gratwohl, A.; Tyndall, A.
1997Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantationLokhorst, H.M.; Schattenberg, A.V.M.B.; Cornelissen, J.J.L.M.; Thomas, L.L.M.; Verdonck, L.F.
1997Empirical and subsequent use of antibacterial agents in the febrile neutropenic patientPauw, B.E. de; Raemaekers, J.M.M.; Schattenberg, A.V.M.B.; Donnelly, J.P.
1997The use of counterflow centrifugation elutriation (CCE) to deplete T cells from allogeneic peripheral blood stem cell graftsPreijers, F.W.M.B.; Schattenberg, A.V.M.B.; Ruijs, P.; Witte, T.J.M. de
1997Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesMattijssen, V.; Schattenberg, A.V.M.B.; Schaap, N.P.M.; Preijers, F.W.M.B.; Witte, T.J.M. de
1997Hooggedoseerde chemotherapie gevolgd door transplantatie van autologe hematopoëtische stamcellen als therapie voor systemische reumatische auto-immuunziektenHoogen, F.H.J. van den; Schattenberg, A.V.M.B.; Breedveld, F.C.; Fibbe, W.; Putte, L.B.A. van de
1997Serial monitoring of aspergillus antigens in the early diagnosis of invasive aspergillosis: preliminary investigations with two examplesVerweij, P.E.; Dompeling, E.C.; Donnelly, J.P.; Schattenberg, A.V.M.B.; Meis, J.F.G.M.
1997Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phaseSchattenberg, A.V.M.B.; Preijers, F.W.M.B.; Mensink, E.J.B.M.; Bär, B.; Schaap, N.P.M.; Geurts van Kessel, A.H.M.; Maazen, R.W.M. van der; Witte, T.J.M. de
1997Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimenSchaap, N.P.M.; Schattenberg, A.V.M.B.; Bär, B.; Preijers, F.W.M.B.; Geurts van Kessel, A.H.M.; Maazen, R.W.M. van der; Boo, T.M. de; Witte, T.J.M. de
1996Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMTSchaap, N.P.M.; Raymakers, R.A.P.; Schattenberg, A.V.M.B.; Ottevanger, J.P.; Witte, T.J.M. de
1996Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemiaGratwohl, A.; Hermans, J.; Biezen, A. van; Arcese, W.; Debusscher, L.; Ernst, P.; Ferrant, A.; Frassoni, F.; Gahrton, G.; Iriondo, A.; Kolb, H.J.; Link, H.; Niederwieser, D.; Ruutu, T.; Schattenberg, A.V.M.B.; Schmitz, N.; Siegert, W.; Torres-Gomez, A.; Vernant, J.P.; Zwaan, F.; Apperley, J.
1996Succes van infusie met lymfocyten als behandeling van leukemierecidief na allogene beenmergtransplantatie is afhankelijk van een laag percentage eigen lymfocytenSchattenberg, A.V.M.B.; Wiel-van Kemenade, E. van de; Bär, B.; Geurts van Kessel, A.H.M.; Maazen, R.W.M. van der; Witte, T.J.M. de

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback